ArticleCancer discovery2025

Defining the Antitumor Mechanism of Action of a Clinical-stage Compound as a Selective Degrader of the Nuclear Pore Complex.

Linjie Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.